INNPF - Innocan Pharma announces successful production of CBD loaded liposomes under aseptic conditions

Innocan Pharma (INNPF) announces a successful manufacturing demonstration of its liposome platform technology ((LPT)) CBD-loaded Liposomes under aseptic conditions, together with the Hebrew University of Jerusalem.These studies follow the results of previous studies that demonstrated the prolonged release of cannabidiol into the blood of mice and rats for at least three weeks after a single injection, the company said.The results of this study may indicate that Innocan's LPT, with only one or two injections per month, may relieve pain or other symptoms when using CBD.

For further details see:

Innocan Pharma announces successful production of CBD loaded liposomes under aseptic conditions